HomeCTXR • NASDAQ
add
Citius Pharmaceuticals Inc
Previous close
$1.65
Day range
$1.54 - $1.70
Year range
$1.49 - $26.75
Market cap
13.41M USD
Avg Volume
150.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.04M | 7.48% |
Net income | -9.77M | -5.82% |
Net profit margin | — | — |
Earnings per share | -1.30 | — |
EBITDA | -10.04M | -7.48% |
Effective tax rate | -2.64% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.10M | -94.59% |
Total assets | 120.70M | 23.93% |
Total liabilities | 51.78M | 329.20% |
Total equity | 68.92M | — |
Shares outstanding | 8.59M | — |
Price to book | 0.20 | — |
Return on assets | -21.15% | — |
Return on capital | -34.98% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -9.77M | -5.82% |
Cash from operations | -4.73M | 22.97% |
Cash from investing | — | — |
Cash from financing | 2.57M | — |
Net change in cash | -2.15M | 64.93% |
Free cash flow | -925.31K | 67.34% |
About
Founded
2007
Headquarters
Website
Employees
23
